Evaluation of serum basal thyrotrophin levels and thyrotrophin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples